Five companies, including Joyson Electronics, Waigaoqiao and Huahai Qingke, issued important announcements
Joyson Electronics: Holding subsidiaries plan to introduce Ningbo Tonggao** and Ningbo Ning**] Joyson Electronics holding subsidiaries plan to introduce Ningbo Tonggao** and Ningbo Ning**.
Joyson Electronics announced that Ningbo Tonggao** and Ningbo Ning** plan to invest 1 billion yuan and 4 billion yuan respectively7.5 billion yuan to acquire the company's subsidiary Anhui Joyson Automotive Safety System Holdings, hereinafter referred to as"Anhui Joyson security"）6.7797% equity and 32203% equity. This transaction is conducive to promoting the development of the company's automotive safety business in the domestic region, further expanding the scale of domestic production and operation, and improving the global competitiveness of products. After the completion of the introduction of strategic investors, the company is expected to hold about 60% of the equity of Anhui Junsheng Security.
Waigaoqiao: Attributable net profit in 2023 decreased by 25 year-on-year18%】。
Waigaoqiao released the 2023 annual performance report, and during the reporting period, the company achieved a total operating income of 780.8 billion yuan, a decrease of 15 from the previous year14%, mainly due to the decrease in real estate sales area and revenue during the year; The company achieved net profit attributable to shareholders of the listed company92.8 billion yuan, a decrease of 2518%, mainly due to the decrease in gross profit from real estate sales in the current year and the higher investment income from the disposal of subsidiaries in the previous year.
Ningbo Port: Cargo volume in February is expected to be 78.7 million tons, down 09%。
The Port of Ningbo announced that its container throughput will reach 3.01 million TEUs by February 2024, with an annual increase of 61%；Cargo throughput will reach 78.7 million tons, with an annual decrease of 09%。
Huahai Qingke: It is planned to repurchase shares for 50 million to 100 million yuan
Huahai Qingke announced that it intends to repurchase shares worth 50 million to 100 million yuan, and repurchase no more than 260 yuan of shares.
Kunming Pharmaceutical Group: 11.74 million yuan investment proposal for the R&D and production of artemisinin-based antimalarial drugs. ］
Kunming Pharmaceutical Group announced that the company invested 11.74 million yuan with its own funds for the research and development and production of artemisinin-based antimalarial drug projects KYCH10-2024-202 and KYCH10-2024-203, which is expected to pass the drug prequalification of the World Health Organization. If the project is successfully launched, it will enrich the company's antimalarial drug product line, help improve the company's overall overseas commercialization capabilities, and contribute to the construction of a community with a shared future for mankind.